Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GW Receives up to $14.6M to Develop Method for Characterizing Security Threats

Published: Wednesday, January 29, 2014
Last Updated: Monday, February 03, 2014
Bookmark and Share
The researchers are tasked with reducing to 30 days a process that can sometimes take years or even decades.

A team led by a George Washington University (GW) researcher will receive up to $14.6 million over five years from the Defense Advanced Research Projects Agency (DARPA) to develop an approach to rapidly identify the root of biological and chemical threats. If successful, the approach could bolster national security efforts to combat these threats.

“Clearly, this is a very large challenge, and it’s easy to understand why it’s important to overcome,” said Akos Vertes, George Washington University professor of chemistry in the Columbian College of Arts and Sciences. “Discovering the cause behind a biological or chemical threat can provide information that not only counteracts the threat but also provides important information for pharmaceutical companies developing drugs that may be unrelated to the threat.”

Biological threats, such as anthrax, derive from bacteria, while others derive from viruses, toxins or fungi.  Chemical threats include substances that work to interfere with the nervous system or even cause asphyxiation. These threats have the potential to cause widespread, rapid injury or death.

To determine how a biological or chemical threat disrupts life functions, researchers must take a holistic view of the threat and the system in which it is working. The team will examine the effects of toxic agents on genes, proteins and cellular functions using the scientific disciplines of transcriptomics, proteomics, metabolomics and bioinformatics to meet the 30-day challenge. By combining an immense amount of data gleaned from these disciplines, researchers believe it will be easier to determine the workings of a given biological or chemical threat in a given environment.

One problem in achieving this, though, is the fact that the field of metabolomics isn’t as well-developed as other scientific disciplines. However, Dr. Vertes and his team at GW recently developed the Laser Ablation Electrospray Ionization (LAESI) technique, which allows researchers to more quickly and effectively learn the chemical composition of a biological sample. The technique was licensed to Protea Biosciences Inc., which developed the commercial product— the LAESI-DP 1000 Direct Ionization System—last year.

GE Global Research, Protea Biosciences Inc., and SRI International will collaborate with GW on this project, titled, “New Tools for Comparative Systems Biology of Threat Agent Action Mechanisms.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Expanding Knowledge of Viral Diversity
Environmental datasets help researchers double the number of microbial phyla known to be infected by viruses.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Using Big Data to Discover Potential Cancer Biomarkers
University of Hawai'i Cancer Center researchers used "Big Data" to discover potential cancer biomarkers, a panel of six long intergenic non-coding RNAs (lincRNAs), for the diagnosis of all types of cancers including lung, breast, prostate, liver and ovarian cancers.
Protecting Privacy in Genomic Databases
System helps ensure databases used in medical research will not leak patients’ personal information.
Algorithm To Find Precise Cancer Treatments For Patients Developed
The JAMMIT algorithm could help predict which patients will benefit most from chemotherapy.
Depression Genetics Insight from Crowd-Sourced Data
Genome sites liked to depression have been discovered from data shared by people who had purchased their genetic profiles online.
Detecting Hazardous Chemicals in Complex Mixtures
Researchers are pioneering a new chemical substance analyis software technique that could increase illicit substance detection.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!